A detailed history of Aviva PLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Aviva PLC holds 1,932 shares of CRL stock, worth $378,227. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,932
Previous 10,173 81.01%
Holding current value
$378,227
Previous $2.1 Million 81.91%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$187.96 - $245.29 $1.55 Million - $2.02 Million
-8,241 Reduced 81.01%
1,932 $380,000
Q2 2024

Aug 02, 2024

BUY
$206.39 - $268.73 $1.7 Million - $2.21 Million
8,233 Added 424.38%
10,173 $2.1 Million
Q1 2024

May 14, 2024

BUY
$203.52 - $273.43 $5,902 - $7,929
29 Added 1.52%
1,940 $525,000
Q3 2023

Nov 13, 2023

SELL
$194.44 - $217.61 $6,610 - $7,398
-34 Reduced 1.75%
1,911 $374,000
Q2 2023

Aug 10, 2023

SELL
$183.71 - $210.25 $10.8 Million - $12.4 Million
-59,026 Reduced 96.81%
1,945 $408,000
Q1 2023

May 12, 2023

BUY
$191.89 - $259.92 $9.77 Million - $13.2 Million
50,900 Added 505.41%
60,971 $12.3 Million
Q4 2022

Feb 09, 2023

SELL
$197.11 - $250.07 $4.14 Million - $5.25 Million
-20,994 Reduced 67.58%
10,071 $2.19 Million
Q3 2022

Nov 14, 2022

SELL
$182.44 - $250.54 $1.73 Million - $2.38 Million
-9,497 Reduced 23.41%
31,065 $6.11 Million
Q2 2022

Aug 04, 2022

BUY
$204.13 - $302.4 $1.62 Million - $2.4 Million
7,940 Added 24.34%
40,562 $8.68 Million
Q1 2022

May 13, 2022

BUY
$255.51 - $362.11 $4.16 Million - $5.89 Million
16,270 Added 99.5%
32,622 $9.26 Million
Q4 2021

Feb 10, 2022

SELL
$351.38 - $448.68 $2.61 Million - $3.34 Million
-7,435 Reduced 31.26%
16,352 $6.16 Million
Q3 2021

Nov 12, 2021

BUY
$372.64 - $458.3 $5.43 Million - $6.68 Million
14,577 Added 158.27%
23,787 $9.82 Million
Q2 2021

Aug 10, 2021

BUY
$294.17 - $371.65 $2.71 Million - $3.42 Million
9,210 New
9,210 $3.41 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.96B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Aviva PLC Portfolio

Follow Aviva PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.